Filing Flows › Comparisons › NVO vs JNJ
Novo Nordisk A S vs Johnson & Johnson: NVO and JNJ compared
Novo Nordisk A S is the larger company: $309.1B of revenue in its latest quarter (FY2025) against $25.4B for Johnson & Johnson (Q3 2026). Novo Nordisk A S is growing faster (+6% against +6% a year earlier). Novo Nordisk A S is more profitable, with an operating margin of 41.3% against 0.1%.
Where the money goes: NVO and JNJ
Novo Nordisk A S (NVO) · FY2025
Novo Nordisk A S, FY2025: revenue $309.1B (+6% year over year), operating margin 41.3%, net earnings $102.4B, operating cash flow $119.1B. The chart follows the revenue to costs, profit and cash.
Johnson & Johnson (JNJ) · Q3 2026
Johnson & Johnson, Q3 2026: revenue $25.4B (+6% year over year), operating margin 0.1%, net earnings $210M, operating cash flow $7.7B. The chart follows the revenue to costs, profit and cash.
| Novo Nordisk A S (NVO) | Johnson & Johnson (JNJ) | |
|---|---|---|
| Latest quarter | FY2025 | Q3 2026 |
| Revenue | $309.1B | $25.4B |
| Revenue growth, Y/Y | +6% | +6% |
| Gross margin | 81.0% | 68.1% |
| Operating margin | 41.3% | 0.1% |
| Net earnings | $102.4B | $210M |
| Net margin | 33.1% | 0.8% |
| Operating cash flow | $119.1B | $7.7B |
| Free cash flow | $59.0B | $6.4B |
| Market value | $186.0B | $676.4B |
| P/E | 1.8× | 42.0× |
| Analysts’ mean target | $45.56 | $279.41 |
Where the revenue comes from
Johnson & Johnson
- Innovative Medicine: $16.8B (66%)
- MEDTECH: $8.6B (34%)
Questions
Which is bigger, Novo Nordisk A S or Johnson & Johnson?
Novo Nordisk A S is the larger company: $309.1B of revenue in its latest quarter (FY2025) against $25.4B for Johnson & Johnson (Q3 2026).
Is Novo Nordisk A S or Johnson & Johnson growing faster?
Novo Nordisk A S is growing faster (+6% against +6% a year earlier).
Which is more profitable, Novo Nordisk A S or Johnson & Johnson?
Novo Nordisk A S is more profitable, with an operating margin of 41.3% against 0.1%.
More: Novo Nordisk A S earnings · how Novo Nordisk A S makes money · Johnson & Johnson earnings · how Johnson & Johnson makes money
From the companies' latest 10-Q, 10-K or earnings release (20-F filed Feb 4, 2026; 10-Q filed Oct 21, 2026). Fiscal quarters can end on different dates. Not investment advice.